Publications

  1. Lieberthal JG, Cuthbertson D, Carette S, Hoffman GS, Khalidi NA, Koening CL, Langford CA, Maksimowicz-McKinnon K, Seo P, Specks U, Ytterberg SR, Merkel PA, Monach PA, Vasculitis Clinical Research Consortium. urinary biomarkers in relapsing antineutrophil cytoplasmic antibody-associated vasculitis. J Rheumatol. 2013 May; 40(5):674-83. Epub 2013 Apr 01. 2314140
    View PubMed
  2. Lopez De Padilla CM, McNallan KT, Crowson CS, Bilgic H, Bram RJ, Hein MS, Ytterberg SR, Amin S, Peterson EJ, Baechler EC, Reed AM. BAFF expression correlates with idiopathic inflammatory myopathy disease activity measures and autoantibodies. J Rheumatol. 2013 Mar; 40(3):294-302. Epub 2013 Jan 15. 2308234
    View PubMed
  3. Kermani TA, Warrington KJ, Crowson CS, Ytterberg SR, Hunder GG, Gabriel SE, Matteson EL. Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosis. Ann Rheum Dis. 2012 Dec 19. [Epub ahead of print] 2292243
    View PubMed
  4. Reed AM, Peterson E, Bilgic H, Ytterberg SR, Amin S, Hein MS, Crowson CS, Ernste F, Gillespie EB. Changes in novel biomarkers of disease activity in juvenile and adult dermatomyositis are sensitive biomarkers of disease course. Arthritis Rheum. 2012 Dec; 64(12):4078-86. 2263941
    View PubMed
  5. Cartin-Ceba R, Golbin JM, Keogh KA, Peikert T, Sanchez-Menendez M, Ytterberg SR, Fervenza FC, Specks U. Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener's): ten-year experience at a single center. Arthritis Rheum. 2012 Nov; 64(11):3770-8. 2253217
    View PubMed
  6. Alexanderson H, Reed AM, Ytterberg SR. The Myositis Activities Profile -- initial validation for assessment of polymyositis/dermatomyositis in the USA. J Rheumatol. 2012 Nov; 39(11):2134-41. Epub 2012 Sep 01. 2267979
    View PubMed
  7. Grayson PC, Maksimowicz-McKinnon K, Clark TM, Tomasson G, Cuthbertson D, Carette S, Khalidi NA, Langford CA, Monach PA, Seo P, Warrington KJ, Ytterberg SR, Hoffman GS, Merkel PA, Vasculitis Clinical Research Consortium. Distribution of arterial lesions in Takayasu's arteritis and giant cell arteritis. Ann Rheum Dis. 2012 Aug; 71(8):1329-34. Epub 2012 Feb 10. 2275158
    View PubMed
  8. Kermani TA, Schmidt J, Crowson CS, Ytterberg SR, Hunder GG, Matteson EL, Warrington KJ. Utility of erythrocyte sedimentation rate and C-reactive protein for the diagnosis of giant cell arteritis. Semin Arthritis Rheum. 2012 Jun; 41(6):866-71. Epub 2011 Nov 25. 2208200
    View PubMed
  9. Grayson PC, Tomasson G, Cuthbertson D, Carette S, Hoffman GS, Khalidi NA, Langford CA, McAlear CA, Monach PA, Seo P, Warrington KJ, Ytterberg SR, Merkel PA, Vasculitis Clinical Research Consortium. Association of vascular physical examination findings and arteriographic lesions in large vessel vasculitis. J Rheumatol. 2012 Feb; 39(2):303-9. Epub 2011 Dec 15. 2256171
    View PubMed
  10. Tomasson G, Boers M, Walsh M, LaValley M, Cuthbertson D, Carette S, Davis JC, Hoffman GS, Khalidi NA, Langford CA, McAlear CA, McCune WJ, Monach PA, Seo P, Specks U, Spiera R, St Clair EW, Stone JH, Ytterberg SR, Merkel PA. Assessment of health-related quality of life as an outcome measure in granulomatosis with polyangiitis (Wegener's). Arthritis Care Res (Hoboken). 2012 Feb; 64(2):273-9. 2228503
    View PubMed
  11. Monach PA, Kumpers P, Lukasz A, Tomasson G, Specks U, Stone JH, Cuthbertson D, Krischer J, Carette S, Ding L, Hoffman GS, Ikle D, Kallenberg CG, Khalidi NA, Langford CA, Seo P, St Clair EW, Spiera R, Tchao N, Ytterberg SR, Haubitz M, Merkel PA. Circulating angiopoietin-2 as a biomarker in ANCA-associated vasculitis. PLoS One. 2012; 7(1):e30197. Epub 2012 Jan 18. 2225586
    View PubMed
  12. Kelley JM, Monach PA, Ji CY, Zhou YB, Wu JM, Tanaka S, Mahr AD, Johnson S, McAlear C, Cuthbertson D, Carette S, Davis JC, Dellaripa PF, Hoffman GS, Khalidi N, Langford CA, Seo P, St Clair EW, Specks U, Stone JH, Spiera RF, Ytterberg SR, Merkel PA, Edberg IgA and IgG antineutrophil cytoplasmic antibody engagement of Fc receptor genetic variants influences granulomatosis with polyangiitis. Proceedings Of The National Academy Of Sciences Of The United States Of. 2011 Dec 20; 108(51):20736-41. 2216625
  13. Clowse ME, Copland SC, Hsieh TC, Chow SC, Hoffman GS, Merkel PA, Spiera RF, Davis JC Jr, McCune WJ, Ytterberg SR, St Clair EW, Allen NB, Specks U, Stone JH, WGET Research Group. Ovarian reserve diminished by oral cyclophosphamide therapy for granulomatosis with polyangiitis (Wegener's). Arthritis Care Res (Hoboken). 2011 Dec; 63(12):1777-81. 2275049
    View PubMed
  14. Monach PA, Tomasson G, Specks U, Stone JH, Cuthbertson D, Krischer J, Ding L, Fervenza FC, Fessler BJ, Hoffman GS, Ikle D, Kallenberg CG, Langford CA, Mueller M, Seo P, St Clair EW, Spiera R, Tchao N, Ytterberg SR, Gu YZ, Snyder RD, Merkel PA. Circulating markers of vascular injury and angiogenesis in antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum. 2011 Dec; 63(12):3988-97. 2211581
    View PubMed
  15. Silva F, Seo P, Schroeder DR, Stone JH, Merkel PA, Hoffman GS, Spiera R, Sebastian JK, Davis JC Jr, St Clair EW, Allen NB, McCune WJ, Ytterberg SR, Specks U, Wegener's Granulomatosis Etanercept Trial Research Group. Solid malignancies among etanercept-treated patients with granulomatosis with polyangiitis (Wegener's): long-term followup of a multicenter longitudinal cohort. Arthritis Rheum. 2011 Aug; 63(8):2495-503. 2157478
    View PubMed
  16. Makol A, Ytterberg SR. Images in clinical medicine. Calcinosis cutis in systemic sclerosis. N Engl J Med. 2011 Jun 9; 364(23):2245. 2170013
    View PubMed
  17. Kermani TA, Ytterberg SR, Warrington KJ. Pneumocystis jiroveci pneumonia in giant cell arteritis: A case series. Arthritis Care Res (Hoboken). 2011 May; 63(5):761-5. 2172303
    View PubMed
  18. McCullough MB, Domire ZJ, Reed AM, Amin S, Ytterberg SR, Chen Q, An KN. Evaluation of muscles affected by myositis using magnetic resonance elastography. Muscle Nerve. 2011 Apr; 43(4):585-90. Epub 2011 Feb 11. 2147532
    View PubMed
  19. Schafer VS, Kermani TA, Crowson CS, Hunder GG, Gabriel SE, Ytterberg SR, Matteson EL, Warrington KJ. Incidence of herpes zoster in patients with giant cell arteritis: a population-based cohort study. Rheumatology (Oxford). 2010 Nov; 49(11):2104-8. Epub 2010 Jul 13. 2106740
    View PubMed
  20. Stone JH, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Turkiewicz A, Tchao NK, Webber L, Ding L, Sejismundo LP, Mieras K, Weitzenkamp D, Ikle D, Seyfert-Margolis V, Mueller M, Brunetta P, Allen NB, Fervenza FC, Geetha Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med. 2010 Jul 15; 363(3):221-32. 2109218
    View PubMed
  21. Kermani TA, Schafer VS, Crowson CS, Hunder GG, Ytterberg SR, Matteson EL, Gabriel SE, Warrington KJ. Cancer preceding giant cell arteritis: a case-control study. Arthritis Rheum. 2010 Jun; 62(6):1763-9. 1988603
    View PubMed
  22. Kermani TA, Schafer VS, Crowson CS, Hunder GG, Gabriel SE, Ytterberg SR, Matteson EL, Warrington KJ. Malignancy risk in patients with giant cell arteritis: a population-based cohort study. Arthritis Care Res (Hoboken). 2010 Feb; 62(2):149-54. 1988605
    View PubMed
  23. Bilgic H, Ytterberg SR, Amin S, McNallan KT, Wilson JC, Koeuth T, Ellingson S, Newman B, Bauer JW, Peterson EJ, Baechler EC, Reed AM. Interleukin-6 and type I interferon-regulated genes and chemokines mark disease activity in dermatomyositis. Arthritis Rheum. 2009 Nov; 60(11):3436-46. 1975960
    View PubMed
  24. Ytterberg SR, Warrington KJ, Daniel Aletaha, Thomas Bush. Vasculitis working group: selected unanswered questions related to giant cell arteritis and anti-neutrophil cytoplasmic antibody-associated vasculitis. Joint Bone Spine. 2009 Jul; 76(4):440-3. Epub 2009 Jun 26. 1951013
    View PubMed
  25. Warrington KJ, Matteson EL, Ytterberg SR. Takayasu Arteritis. BMJ Point of Care Epocrates online. 2009 Mar 23. 2167478
  26. Finkielman JD, Merkel PA, Schroeder D, Hoffman GS, Spiera R, St Clair EW, Davis JC Jr, McCune WJ, Lears A, Ytterberg SR, Hummel AM, Viss MA, Peikert T, Stone JH, Specks U, WGET Research Group. Glycosylation of proteinase 3 (PR3) is not required for its reactivity with antineutrophil cytoplasmic antibodies (ANCA) in Wegener's granulomatosis. Clin Exp Rheumatol. 2009 Jan-Feb; 27(1 Suppl 52):S45-52. 1980485
    View PubMed
  27. Wilson FC, Ytterberg SR, St Sauver JL, Reed AM. Epidemiology of sporadic inclusion body myositis and polymyositis in Olmsted County, Minnesota. J Rheumatol. 2008 Mar; 35(3):445-7. Epub 2008 Jan 15. 1947081
    View PubMed
  28. Finkielman JD, Merkel PA, Schroeder D, Hoffman GS, Spiera R, St Clair EW, Davis JC Jr, McCune WJ, Lears AK, Ytterberg SR, Hummel AM, Viss MA, Peikert T, Stone JH, Specks U, WGET Research Group. Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosis. Ann Intern Med. 2007 Nov 6; 147(9):611-9. 1853615
    View PubMed
  29. Finkielman JD, Lee AS, Hummel AM, Viss MA, Jacob GL, Homburger HA, Peikert T, Hoffman GS, Merkel PA, Spiera R, St Clair EW, Davis JC Jr, McCune WJ, Tibbs AK, Ytterberg SR, Stone JH, Specks U, WGET Research Group. ANCA are detectable in nearly all patients with active severe Wegener's granulomatosis. Am J Med. 2007 Jul; 120(7):643.e9-14. 1828232
    View PubMed
  30. Seo P, Luqmani RA, Flossmann O, Hellmich B, Herlyn K, Hoffman GS, Jayne D, Kallenberg CG, Langford CA, Mahr A, Matteson EL, Mukhtyar CB, Neogi T, Rutgers A, Specks U, Stone JH, Ytterberg SR, Merkel PA. The future of damage assessment in vasculitis. J Rheumatol. 2007 Jun; 34(6):1357-71. 1830768
    View PubMed
  31. Baechler EC, Bauer JW, Slattery CA, Ortmann WA, Espe KJ, Novitzke J, Ytterberg SR, Gregersen PK, Behrens TW, Reed AM. An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activity. Mol Med. 2007 Jan-Feb; 13(1-2):59-68. 1827902
    View PubMed
  32. Orzechowski NM, Ytterberg SR. 37-year-old woman with headache. Mayo Clin Proc. 2006 Oct; 81(10):1393-6. 1786752
    View PubMed
  33. Ytterberg SR. Treatment of refractory polymyositis and dermatomyositis. Curr Rheumatol Rep. 2006 Jun; 8(3):167-73. 1775831
    View PubMed
  34. Stone JH, Holbrook JT, Marriott MA, Tibbs AK, Sejismundo LP, Min YI, Specks U, Merkel PA, Spiera R, Davis JC, St Clair EW, McCune WJ, Ytterberg SR, Allen NB, Hoffman GS, Wegener's Granulomatosis Etanercept Trial Research Group. Solid malignancies among patients in the Wegener's Granulomatosis Etanercept Trial. Arthritis Rheum. 2006 May; 54(5):1608-18. 1968725
    View PubMed
  35. Keogh KA, Ytterberg SR, Fervenza FC, Carlson KA, Schroeder DR, Specks U. Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial. Am J Respir Crit Care Med. 2006 Jan 15; 173(2):180-7. Epub 2005 Oct 13. 1744249
    View PubMed
  36. Seo P, Min YI, Holbrook JT, Hoffman GS, Merkel PA, Spiera R, Davis JC, Ytterberg SR, St Clair EW, McCune WJ, Specks U, Allen NB, Luqmani RA, Stone JH. Damage caused by Wegener's granulomatosis and its treatment - Prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET). Arthritis Rheum. 2005 Jul; 52(7):2168-78. 1729788
    View PubMed
  37. Davis JM 3rd, Moder KG, Homburger HA, Ytterberg SR. Clinical features of 39 patients with antibodies to extractable nuclear antigens despite negative antinuclear antibodies: evidence for autoimmunity including neurologic and connective tissue diseases. Medicine (Baltimore) 2005 Jul; 84(4):208-17. 1720460
    View PubMed
  38. The Wegener’s Granulomatosis Etanercept Trial Research Group. Etanercept plus standard therapy for Wegener’s granulomatosis. N Engl J Med. 2005; 352(4):351-61. 2167505
  39. Wung PK, Holbrook JT, Hoffman GS, Tibbs AK, Specks U, Min Y-I, Merkel PA, Spiera R, Davis JC, St. Clair EW, McCune J, Ytterberg SR, Allen NB, Stone JH, for the WGET Research Group. Herpes zoster in immunocompromised patients: Incidence, timing, and risk factors. Am J Med. 2005; 118(12):1416.e9-18. 2167510
    View PubMed
  40. Leung N, Ytterberg SR, Blute ML, Lager DJ, Specks U, Fervenza FC. Wegener's granulomatosis presenting as multiple bilateral renal masses. Nephrol Dial Transplant. 2004 Apr; 19(4):984-7. 1642948
    View PubMed
  41. Stone JH, The WGET Research Group. Limited versus severe Wegener’s granulomatosis: Baseline data on patients in the Wegener’s granulomatosis etanercept trial. Arthritis Rheum. 2003; 48(8):2299-309. 2167493
  42. Rider LG, Giannini EH, Harris-Love M, Joe G, Isenberg D, Pilkington C, Lachenbruch PA, Miller FW, International Myositis Assessment Clinical Studies Group. Defining clinical improvement in adult and juvenile myositis. J Rheumatol. 2003; 30(3):603-17. 2167498
  43. Reed AM, Ytterberg SR. Genetic and environmental risk factors for idiopathic inflammatory myopathies. Rheum Dis Clin North Am. 2002 Nov; 28(4):891-916. 1317740
    View PubMed
  44. WGET Research Group. Design of the Wegener's Granulomatosis Etanercept Trial (WGET). Control Clin Trials. 2002 Aug; 23(4):450-68. 2148634
    View PubMed
  45. Cranmer LD, Warrington KJ, Ytterberg SR. 61-year-old man with dyspnea and bilateral foot drop. Mayo Clin Proc. 2002 Apr; 77(4):363-6. 1315370
    View PubMed
  46. Miller FW, Rider LG, Chung YL, Cooper R, Danko K, Farewell V, Lundberg I, Morrison C, Oakley L, Oakley I, Pilkington C, Vencovsky J, Vincent K, Scott DL, Isenberg DA, International Myositis Outcome Assessment Collaborative Study Group. Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies. Rheumatology (Oxford). 2001 Nov; 40(11):1262-73. 2147433
    View PubMed
  47. Ytterberg SR. Polymyalgia rheumatica: Clinical features and management. Primary Care Case Reviews. 2001; 4(2):89-95. 1652434
    View PubMed
  48. Ytterberg SR. Viral arthritis. Curr Opin Rheumatol. 1999 Jul; 11(4):275-80. 1010093
    View PubMed
  49. Johnson JR, Burke MS, Mahowald ML, Ytterberg SR. Life-threatening reaction to vancomycin given for noninfectious fever. Ann Pharmacotherapy. 1999; 33(10):1043-5. 145046
  50. Ytterberg SR, Harris IB, Allen SS, Anderson DC, Kofron PM, Kvasnicka JH, McCord JP, Moller JH. Clinical confidence and skills of medical students: use of an OSCE to enhance confidence in clinical skills. Acad Med. 1998 Oct; 73(10 Suppl):S103-5. 115684
    View PubMed
  51. Ytterberg SR, Mahowald ML, Woods SR. Codeine and oxycodone use in patients with chronic rheumatic disease pain. Arthritis Rheum. 1998 Sep; 41(9):1603-12. 115685
    View PubMed
  52. Stern EB, Callinan N, Hank M, Lewis EJ, Schousboe JT, Ytterberg SR. Neoprene splinting: dermatological issues. Am J Occup Ther. 1998 Jul-Aug; 52(7):573-8. 115686
    View PubMed
  53. Ytterberg SR, Plotnikoff GA, Harris IB. Teaching professionalism through tutorial discussions of literature--stories, poems, and essays. Acad Med. 1998 May; 73(5):575-6. 115687
    View PubMed
  54. Stern EB, Ytterberg SR, Krug HE, Larson LM, Portoghese CP, Kratz WN, Mahowald ML. Commercial wrist extensor orthoses: a descriptive study of use and preference in patients with rheumatoid arthritis. Arthritis Care & Research. 1997 Feb; 10(1):27-35. 115688
    View PubMed
  55. Krug HE, Wietgrefe MM, Ytterberg SR, Taurog JD, Mahowald ML. Murine progressive ankylosis is not immunologically mediated. J Rheumatol. 1997 Jan; 24(1):115-22. 115690
    View PubMed
  56. Allen S, Harris I, Ytterberg S, Anderson D, Kofron P, Kvasnicka J, Moller JH. Tailored response test: a new approach for teaching in medical education. Med Teach. 1997; 19(3):194-199. 1017758
  57. Ytterberg SR. Infectious agents associated with myopathies. Curr Opin Rheumatol. 1996 Nov; 8(6):507-13. 115689
    View PubMed
  58. Stern EB, Ytterberg SR, Krug HE, Mahowald ML. Finger dexterity and hand function: effect of three commercial wrist extensor orthoses on patients with rheumatoid arthritis. Arthritis Care & Research. 1996 Jun; 9(3):197-205. 115691
    View PubMed
  59. Harris IB, Kvasnicka JH, Ytterberg SR. Faculty development for community primary care preceptors. Acad Med. 1996 May; 71(5):567-8. 1027497
    View PubMed
  60. Stern EB, Ytterberg SR, Krug HE, Mullin GT, Mahowald ML. Immediate and short-term effects of three commercial wrist extensor orthoses on grip strength and function in patients with rheumatoid arthritis. Arthritis Care & Research. 1996 Feb; 9(1):42-50. 115692
    View PubMed
  61. Pachman LM, Litt DL, Rowley AH, Hayford JR, Caliendo J, Heller S, Ticho BS, Christensen M, Patterson B, Ytterberg SR. Lack of detection of enteroviral RNA or bacterial DNA in magnetic resonance imaging-directed muscle biopsies from twenty children with active untreated juvenile dermatomyositis. Arthritis Rheum. 1995 Oct; 38(10):1513-8. 115693
    View PubMed
  62. Harris IB, Kvasnicka JH, Ytterberg SR. Faculty development for community primary care preceptors. Acad Med. 1995 May; 70(5):458-9. 115694
    View PubMed
  63. Kvasnicka JH, Harris IB, Ytterberg SR. A program to provide early exposure to primary care role models: multiple benefits. Acad Med. 1995 May; 70(5):448-9. 115695
    View PubMed
  64. Kvasnicka JH, Harris IB, Ytterberg SR. Using a student advisory group for curriculum assessment. Acad Med. 1995 May; 70(5):430-1. 115696
    View PubMed
  65. Ytterberg SR. The relationship of infectious agents to inflammatory myositis. Rheum Dis Clin North Am. 1994 Nov; 20(4):995-1015. 115697
    View PubMed
  66. Ytterberg SR, Watson K, Kvasnicka JH. Teaching and evaluating awareness of cultural and ethnic diversity in the medical encounter. Acad Med. 1994 May; 69(5):411-2. 115698
    View PubMed
  67. Tam PE, Schmidt AM, Ytterberg SR, Messner RP. Duration of virus persistence and its relationship to inflammation in the chronic phase of coxsackievirus B1-induced murine polymyositis. Journal of Laboratory & Clinical Medicine. 1994 Mar; 123(3):346-56. 1021770
    View PubMed
  68. Ytterberg SR, Mahowald ML, Krug HE. Exercise for arthritis. Baillieres Clin Rheumatol. 1994 Feb; 8(1):161-89. 115699
    View PubMed
  69. Ytterberg SR, Harris IB, Satran L, Allen SS, Anderson DC, Kofron PM, Moller JH, Whitley K, Miller WJ. Use of interactive computer technology with an innovative testing format - the tailored response test. Med Teach. 1994; 16(4):323-332. 1034076
  70. Ytterberg SR, Roelofs RI, Mahowald ML. Inclusion body myositis and renal cell carcinoma. Report of two cases and review of the literature. Arthritis Rheum. 1993 Mar; 36(3):416-21. 115701
    View PubMed
  71. Ytterberg SR. Animal models of myopathy. Curr Opin Rheumatol. 1991 Dec; 3(6):934-40. 115702
    View PubMed
  72. Tam PE, Schmidt AM, Ytterberg SR, Messner RP. Viral persistence during the developmental phase of Coxsackievirus B1-induced murine polymyositis. J Virol. 1991 Dec; 65(12):6654-60. 115703
    View PubMed
  73. Ytterberg SR, Mahowald ML. Bacterial arthritis and osteitis in adults. Curr Opin Rheumatol. 1990 Aug; 2(4):606-15. 115704
    View PubMed
  74. Mahowald ML, Krug H, Steveken ME, Ytterberg SR. Physical therapy for rheumatoid arthritis. J Musculoskeletal Med. 1990; 7(6):52-68. 1035792
  75. Mahowald MW, Mahowald ML, Bundlie SR, Ytterberg SR. Sleep fragmentation in rheumatoid arthritis. Arthritis Rheum. 1989 Aug; 32(8):974-83. 115705
    View PubMed
  76. Ytterberg SR. Cellular immunity in polymyositis/dermatomyositis. Mt Sinai J Med. 1988 Nov; 55(6):494-500. 115706
    View PubMed
  77. Mahowald ML, Steveken ME, Young M, Ytterberg SR. The Minnesota Arthritis Training Program: emphasis on self-management, not compliance. Patient Education & Counseling. 1988 Jun; 11(3):235-41. 1044731
    View PubMed
  78. Ytterberg SR, Mahowald ML, Messner RP. T cells are required for coxsackievirus B1 induced murine polymyositis. J Rheumatol. 1988 Mar; 15(3):475-8. 115707
    View PubMed
  79. Ytterberg SR, Knodell RG, Mahowald ML. Use of the aminopyrine breath test to monitor hepatotoxicity caused by methotrexate in the treatment of rheumatoid arthritis. Contemp Orthop. 1988; 16(5):59-65. 1044199
  80. Mahowald ML, Ytterberg SR. A model for diagnostic decision making: a systemic approach to the patient with "joint pain". Cyberlog. 1988; 2(4):3-9. 1044191
  81. Mahowald ML, Krug HE, Ytterberg SR. Integration of the musculoskeletal examination into diagnostic decision-making. Cyberlog. 1988; 2(4):11-22. 1044192
  82. Mahowald ML, Ytterberg SR. Laboratory tests to aid in the diagnosis of joint pain. Cyberlog. 1988; 2(4):25-27. 1044194
  83. Ytterberg SR, Mahowald ML. Management strategies for inflammatory arthritis. Cyberlog. 1988; 2(4):29-45. 1044195
  84. Ytterberg SR, Knodell RG, Mahowald ML. Lack of methotrexate hepatotoxicity in rheumatoid arthritis. Contemp Gastroenterol. 1988; 1(1):21-26. 1044197
  85. Ytterberg SR, Mahowald ML, Messner RP. Coxsackievirus B 1-induced polymyositis. Lack of disease expression in nu/nu mice. J Clin Invest. 1987 Aug; 80(2):499-506. 115708
    View PubMed
  86. Ytterberg SR. Coxsackievirus B 1 induced murine polymyositis: acute infection with active virus is required for myositis. J Rheumatol. 1987 Feb; 14(1):12-8. 115709
    View PubMed
  87. Mahowald ML, Steveken ME, Ytterberg SR. Arthritis training program. Patient Education Newsletter (Mpls VAMC). 1987; 1(3):1-2. 1041274
  88. Ytterberg SR, Schnitzer TJ. Inhibition of natural killer cell activity by serum from patients with systemic lupus erythematosus: roles of disease activity and serum interferon. Ann Rheum Dis. 1984 Jun; 43(3):457-61. 115710
    View PubMed
  89. Ytterberg SR, Huard TK, Schnitzer TJ. Effects of serum from patients with system lupus erythematosus on leukocyte cytotoxicity: modulation of NK activity and ADCC. J Rheumatol. 1983 Dec; 10(6):906-12. 115711
    View PubMed
  90. Ytterberg SR, Schnitzer TJ. Serum interferon levels in patients with systemic lupus erythematosus. Arthritis Rheum. 1982 Apr; 25(4):401-6. 115712
    View PubMed